Video_1_Balloon pulmonary angioplasty can be an effective and safe therapeutic option in non-surgical elderly patients.AVI

التفاصيل البيبلوغرافية
العنوان: Video_1_Balloon pulmonary angioplasty can be an effective and safe therapeutic option in non-surgical elderly patients.AVI
المؤلفون: Maite Velázquez Martín, Nicolás Maneiro Melón, Agustín Albarrán González-Trevilla, Fernando Sarnago Cebada, Sergio Huertas Nieto, Alejandro Cruz-Utrilla, Williams Hinojosa, María Jesús López-Gude, Sergio Alonso Charterina, Yolanda Revilla Ostolaza, Ricardo José Aguilar Colindres, Fernando Arribas Ynsaurriaga, Pilar Escribano Subias
سنة النشر: 2022
المجموعة: Frontiers: Figshare
مصطلحات موضوعية: Cardiology, Cardiology (incl. Cardiovascular Diseases), Cardiorespiratory Medicine and Haematology not elsewhere classified, balloon pulmonary angioplasty (BPA), chronic thromboembolic pulmonary hypertension (CTEPH), pulmonary hypertension, survival, elderly patients, complications, hemodynamic benefits, reference center
الوصف: Background Advanced age, frailty, and age-related comorbidities are the major causes of pulmonary endarterectomy disqualification in patients with chronic thromboembolic pulmonary hypertension (CTEPH). Balloon pulmonary angioplasty (BPA) is an attractive and less invasive therapy for elderly patients. However, information about the safety, procedure tolerance, and effectiveness of BPA in elderly patients is limited. Objective and methods We aimed to analyze the safety, tolerance, and efficacy of BPA in CTEPH patients aged ≥70 years. This observational, descriptive, and retrospective series included consecutive patients aged ≥70 years, who underwent completed or interrupted BPA programs at a pulmonary hypertension reference center between May 2013 and May 2022. Results We enrolled 155 patients in our institution's BPA program. Among these, 33 patients were aged ≥70 years (mean age, 76.4 years; women, 75.8%) and had finished or interrupted BPA programs. In this cohort, we performed 116 BPA procedures (average, 3.6 ± 1.8 sessions/patient). Among the 33 patients, 19 (57.6%) completed treatment for all lobes, while the BPA program was interrupted in the remaining 14 (42.4%). Among all 33 patients, BPA was associated with a significant reduction in mean pulmonary arterial pressure (39.2 ± 9.3 vs. 32.8 ± 8.8 mmHg; p < 0.001) and pulmonary vascular resistance (6.7 ± 3.1 vs. 4.4 ± 2.0 WU; p < 0.001), along with an improvement in the cardiac index (2.5 ± 0.6 vs. 2.8 ± 0.7 L/min/m 2 ; p = 0.04) with significant reductions in the N-terminal prohormone of brain natriuretic peptide level (pre-BPA, 353 pg/mL [207–1,960 pg/mL] vs. post-BPA, 167 pg/mL [73–629 pg/mL]; p = 0.03). The patients' functional class improved, and pulmonary hypertension-targeting drug requirements were significantly reduced. The pulmonary injury appeared in 3.4% of the 116 procedures, of which 50% were of grade 2. No patient of ≥70 years had grade 5 pulmonary injury. One periprocedural mortality was recorded (3%), and the median follow-up period ...
نوع الوثيقة: dataset
اللغة: unknown
Relation: https://figshare.com/articles/media/Video_1_Balloon_pulmonary_angioplasty_can_be_an_effective_and_safe_therapeutic_option_in_non-surgical_elderly_patients_AVI/21391983
DOI: 10.3389/fcvm.2022.1001518.s001
الاتاحة: https://doi.org/10.3389/fcvm.2022.1001518.s001
https://figshare.com/articles/media/Video_1_Balloon_pulmonary_angioplasty_can_be_an_effective_and_safe_therapeutic_option_in_non-surgical_elderly_patients_AVI/21391983
Rights: CC BY 4.0
رقم الانضمام: edsbas.B37B8644
قاعدة البيانات: BASE
الوصف
DOI:10.3389/fcvm.2022.1001518.s001